Unity receives first order for new BD Italian Tablet press

NewsGuard 100/100 Score

Unity Management Group, Inc. (PINKSHEETS: UYMG) "UNITY" (or the "Company") is a Health Resource Company specializing in Physician, and Hospital Practice Management, Business Services, Billing Software and Technologies, along with Pharmacy Instrumentation, Calibration, Data Acquisition, and Equipment Distribution.

Unity Management Group, Inc. ("UNITY") (OTCMARKETS: UYMG) announced today it has received the first order for their new Italian Tablet press. This order will exceed $450,000 and will be used in one of the largest pharmaceutical production companies in South America. They also are looking for the services of MCC's Instrumentation, Data Acquisition, and calibration upgrades for more than twenty older tablet presses, and other existing equipment.

"This is a great opportunity for MCC, and will open up a huge market for our company in South America, and will solidify our distribution agreement with BD Italia," said Ron Berman of MCC. Many countries are becoming more in line with the requirements that the United States has set in production of pharmaceutical products worldwide, and this will only help to increase our revenues into 2012.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
From farm to pharmacy: Transgenic cow milk as a new source of human insulin